La sierologia del Lupus eritematoso

Translated title of the contribution: Serology of Lupus erythematosis

A. Parodi, E. Cozzani, M. Drosera

Research output: Contribution to journalArticle

Abstract

Lupus erythematosus (LE), expecially its systemic form (SLE), is serologically characterized by the presence of autoantibodies directed to nuclear, cytoplasmic and cellular membrane antigens. Some of them are specific of the disease, others characterize only particular substes. Antinuclear antibodies (ANA) can be detected by various assays: indirect immunofluorescence (IIF), immunodiffusion (ID), counterimmunoelectrophoresis (CIE), enzyme linked immunosorbent assay (ELISA), radioimmunoassay (RIA) and immunoblotting (IB). IIF and ELISA are the most used. ELISA is very sensitive, IIF is sensitive, easy to perform and cheap. In IIF monolayers of cultured cells particularly Hep-2 are the best substrate to use. Antibodies to ds-DNA are high specific of SLE and can be used to monitor the clinical course of the disease. Anti-nucleosome antibodies are now considered the major autoantibodies in SLE and they probably play an important pathogenetic role. Anti-histone antibodies are the marker of drug-induced SLE but they are found also in other diseases. Antibodies to Sm are a highly specific marker for SLE but their sensitivity is low. They are correlated to renal and central nervous system involvements. Anti RNP antibodies are the marker of Sharp's sydrome but can be found in patients with SLE as well. Anti SB/La and anti SSA/RO antibodies are found in Sjogren'syndrome but they characterize also neonatal lupus erythematosus (NLE) with congenital heart block and, anti SSA/Ro, also subacute cutaneous lupus erythematosus (SCLE) with photosensitivity. Anti proliferating-cell-nuclear-antigen antibodies are found in 5-10% of SLE patients with arhritis and hypocomplementemia. Anti Ki antibodies and anti ASE-1 antibodies have been recently described, the letter are correlated with renal involvement. Anti ribosomal antibodies are usually associated with LE psychosis and anti phospholipid antibodies with thrombosis, recurrent pregnancy loss, thrombocytopenia, hemolytic anemia, livedo reticularis and skin ulcers. Anti phospholipid antibodies can be found also in patients without LE. Anti C1q antibodies can be found in SLE patients with nephritis.

Original languageItalian
Pages (from-to)239-249
Number of pages11
JournalGiornale Italiano di Dermatologia e Venereologia
Volume139
Issue number3
Publication statusPublished - 2004

Fingerprint

Serology
Anti-Idiotypic Antibodies
Indirect Fluorescent Antibody Technique
Antibodies
Enzyme-Linked Immunosorbent Assay
Autoantibodies
Phospholipids
Livedo Reticularis
Cutaneous Lupus Erythematosus
Counterimmunoelectrophoresis
Skin Ulcer
Kidney
Nucleosomes
Nephritis
Immunodiffusion
Antinuclear Antibodies
Hemolytic Anemia
Sjogren's Syndrome
Proliferating Cell Nuclear Antigen
Immunoblotting

ASJC Scopus subject areas

  • Dermatology

Cite this

La sierologia del Lupus eritematoso. / Parodi, A.; Cozzani, E.; Drosera, M.

In: Giornale Italiano di Dermatologia e Venereologia, Vol. 139, No. 3, 2004, p. 239-249.

Research output: Contribution to journalArticle

Parodi, A, Cozzani, E & Drosera, M 2004, 'La sierologia del Lupus eritematoso', Giornale Italiano di Dermatologia e Venereologia, vol. 139, no. 3, pp. 239-249.
Parodi, A. ; Cozzani, E. ; Drosera, M. / La sierologia del Lupus eritematoso. In: Giornale Italiano di Dermatologia e Venereologia. 2004 ; Vol. 139, No. 3. pp. 239-249.
@article{6b6ba52f66184a10860b651709b06915,
title = "La sierologia del Lupus eritematoso",
abstract = "Lupus erythematosus (LE), expecially its systemic form (SLE), is serologically characterized by the presence of autoantibodies directed to nuclear, cytoplasmic and cellular membrane antigens. Some of them are specific of the disease, others characterize only particular substes. Antinuclear antibodies (ANA) can be detected by various assays: indirect immunofluorescence (IIF), immunodiffusion (ID), counterimmunoelectrophoresis (CIE), enzyme linked immunosorbent assay (ELISA), radioimmunoassay (RIA) and immunoblotting (IB). IIF and ELISA are the most used. ELISA is very sensitive, IIF is sensitive, easy to perform and cheap. In IIF monolayers of cultured cells particularly Hep-2 are the best substrate to use. Antibodies to ds-DNA are high specific of SLE and can be used to monitor the clinical course of the disease. Anti-nucleosome antibodies are now considered the major autoantibodies in SLE and they probably play an important pathogenetic role. Anti-histone antibodies are the marker of drug-induced SLE but they are found also in other diseases. Antibodies to Sm are a highly specific marker for SLE but their sensitivity is low. They are correlated to renal and central nervous system involvements. Anti RNP antibodies are the marker of Sharp's sydrome but can be found in patients with SLE as well. Anti SB/La and anti SSA/RO antibodies are found in Sjogren'syndrome but they characterize also neonatal lupus erythematosus (NLE) with congenital heart block and, anti SSA/Ro, also subacute cutaneous lupus erythematosus (SCLE) with photosensitivity. Anti proliferating-cell-nuclear-antigen antibodies are found in 5-10{\%} of SLE patients with arhritis and hypocomplementemia. Anti Ki antibodies and anti ASE-1 antibodies have been recently described, the letter are correlated with renal involvement. Anti ribosomal antibodies are usually associated with LE psychosis and anti phospholipid antibodies with thrombosis, recurrent pregnancy loss, thrombocytopenia, hemolytic anemia, livedo reticularis and skin ulcers. Anti phospholipid antibodies can be found also in patients without LE. Anti C1q antibodies can be found in SLE patients with nephritis.",
keywords = "Lupus erythematosu, scutaneous, sierology, Lupus erythematosus, cutaneous, diagnosis, Lupus erythematosus, cutaneous, immunology",
author = "A. Parodi and E. Cozzani and M. Drosera",
year = "2004",
language = "Italian",
volume = "139",
pages = "239--249",
journal = "Minerva dermatologica",
issn = "0392-0488",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "3",

}

TY - JOUR

T1 - La sierologia del Lupus eritematoso

AU - Parodi, A.

AU - Cozzani, E.

AU - Drosera, M.

PY - 2004

Y1 - 2004

N2 - Lupus erythematosus (LE), expecially its systemic form (SLE), is serologically characterized by the presence of autoantibodies directed to nuclear, cytoplasmic and cellular membrane antigens. Some of them are specific of the disease, others characterize only particular substes. Antinuclear antibodies (ANA) can be detected by various assays: indirect immunofluorescence (IIF), immunodiffusion (ID), counterimmunoelectrophoresis (CIE), enzyme linked immunosorbent assay (ELISA), radioimmunoassay (RIA) and immunoblotting (IB). IIF and ELISA are the most used. ELISA is very sensitive, IIF is sensitive, easy to perform and cheap. In IIF monolayers of cultured cells particularly Hep-2 are the best substrate to use. Antibodies to ds-DNA are high specific of SLE and can be used to monitor the clinical course of the disease. Anti-nucleosome antibodies are now considered the major autoantibodies in SLE and they probably play an important pathogenetic role. Anti-histone antibodies are the marker of drug-induced SLE but they are found also in other diseases. Antibodies to Sm are a highly specific marker for SLE but their sensitivity is low. They are correlated to renal and central nervous system involvements. Anti RNP antibodies are the marker of Sharp's sydrome but can be found in patients with SLE as well. Anti SB/La and anti SSA/RO antibodies are found in Sjogren'syndrome but they characterize also neonatal lupus erythematosus (NLE) with congenital heart block and, anti SSA/Ro, also subacute cutaneous lupus erythematosus (SCLE) with photosensitivity. Anti proliferating-cell-nuclear-antigen antibodies are found in 5-10% of SLE patients with arhritis and hypocomplementemia. Anti Ki antibodies and anti ASE-1 antibodies have been recently described, the letter are correlated with renal involvement. Anti ribosomal antibodies are usually associated with LE psychosis and anti phospholipid antibodies with thrombosis, recurrent pregnancy loss, thrombocytopenia, hemolytic anemia, livedo reticularis and skin ulcers. Anti phospholipid antibodies can be found also in patients without LE. Anti C1q antibodies can be found in SLE patients with nephritis.

AB - Lupus erythematosus (LE), expecially its systemic form (SLE), is serologically characterized by the presence of autoantibodies directed to nuclear, cytoplasmic and cellular membrane antigens. Some of them are specific of the disease, others characterize only particular substes. Antinuclear antibodies (ANA) can be detected by various assays: indirect immunofluorescence (IIF), immunodiffusion (ID), counterimmunoelectrophoresis (CIE), enzyme linked immunosorbent assay (ELISA), radioimmunoassay (RIA) and immunoblotting (IB). IIF and ELISA are the most used. ELISA is very sensitive, IIF is sensitive, easy to perform and cheap. In IIF monolayers of cultured cells particularly Hep-2 are the best substrate to use. Antibodies to ds-DNA are high specific of SLE and can be used to monitor the clinical course of the disease. Anti-nucleosome antibodies are now considered the major autoantibodies in SLE and they probably play an important pathogenetic role. Anti-histone antibodies are the marker of drug-induced SLE but they are found also in other diseases. Antibodies to Sm are a highly specific marker for SLE but their sensitivity is low. They are correlated to renal and central nervous system involvements. Anti RNP antibodies are the marker of Sharp's sydrome but can be found in patients with SLE as well. Anti SB/La and anti SSA/RO antibodies are found in Sjogren'syndrome but they characterize also neonatal lupus erythematosus (NLE) with congenital heart block and, anti SSA/Ro, also subacute cutaneous lupus erythematosus (SCLE) with photosensitivity. Anti proliferating-cell-nuclear-antigen antibodies are found in 5-10% of SLE patients with arhritis and hypocomplementemia. Anti Ki antibodies and anti ASE-1 antibodies have been recently described, the letter are correlated with renal involvement. Anti ribosomal antibodies are usually associated with LE psychosis and anti phospholipid antibodies with thrombosis, recurrent pregnancy loss, thrombocytopenia, hemolytic anemia, livedo reticularis and skin ulcers. Anti phospholipid antibodies can be found also in patients without LE. Anti C1q antibodies can be found in SLE patients with nephritis.

KW - Lupus erythematosu, scutaneous, sierology

KW - Lupus erythematosus, cutaneous, diagnosis

KW - Lupus erythematosus, cutaneous, immunology

UR - http://www.scopus.com/inward/record.url?scp=3042715444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042715444&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:3042715444

VL - 139

SP - 239

EP - 249

JO - Minerva dermatologica

JF - Minerva dermatologica

SN - 0392-0488

IS - 3

ER -